SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹86 Cr | ₹79 Cr | ₹119 Cr | ₹93 Cr | ₹43 Cr |
What is the latest Total Debt ratio of SAKAR HEALTHCARE ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹86 Cr |
| Mar2024 | ₹79 Cr |
| Mar2023 | ₹119 Cr |
| Mar2022 | ₹93 Cr |
| Mar2021 | ₹43 Cr |
How is Total Debt of SAKAR HEALTHCARE Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹86 Cr | 8.85 | |
| Mar2024 | ₹79 Cr | -33.42 | |
| Mar2023 | ₹119 Cr | 28.34 | |
| Mar2022 | ₹93 Cr | 118.00 | |
| Mar2021 | ₹43 Cr | - | |
Compare Total Debt of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,572.0 Cr | 4.5% | 26.2% | 239.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 4.5% |
26.2% |
239.2% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses